Author: ddAdmin
Active Pharmaceutical Ingredient (API)
Design, synthesis and profiling of proteolysis-targeting chimeras (PROTACs) as CDK4/6 degraders
In silico and in vitro analysis of the genotoxic and mutagenic potential of STING modulators
Jubilant Biosys Limited seals deal with Pierre Fabre SA
Jubilant Biosys Limited to add Drug Discovery & Preclinical Development capabilities in Biologics and Antibody Drug Conjugate
